Prevalence of adenomyosis in adolescents: diagnostic process and symptoms. Systematic review
Abstract
Background: Adenomyosis is a uterine disorder commonly associated with painful menstrual cycles, abnormal uterine bleeding, and dyspareunia, which can significantly impact fertility, pregnancy outcomes and overall quality of life. Recent literature reports suggest that adenomyosis is increasingly being identified in adolescents, particularly in those presenting with severe dysmenorrhea and heavy menstrual bleeding. In this review we evaluate the frequency of adenomyosis diagnosis on imaging studies in relation to the occurrence of dysmenorrhea, pelvic pain and heavy menstrual bleeding (HMB).
Methods: A thorough literature search was performed using PubMed, EMBASE and SCOPUS databases. It was confined to articles published from 1 January 2019, to 1 August 2024 and included only those available in English. Due to the very limited number of publications on this topic, an age range of 12–25 years was selected as the inclusion criteria. For articles that met the inclusion criteria, information regarding diagnosis on imaging and relation to the occurrence of symptoms was extracted.
Results: Five full-text articles were reviewed. Studies including adolescents and young women from 12–25 years of age who presented with HMB, pelvic pain, dysmenorrhea and an imaging-based diagnosis of adenomyosis. The prevalence of adenomyosis in this population ranged from 25 to 45%. It is crucial to consider adenomyosis in the differential diagnosis of adolescent girls presenting with dysmenorrhea, heavy menstrual bleeding, and pelvic pain. Dysmenorrhea was the most frequently reported symptom (from 81 to 100%) associated with imaging features of adenomyosis.
Keywords: adenomyosisadolescentultrasoundMRIpelvic painHMB
References
- Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006; 20(4): 511–521.
- Upson K, Missmer SA. Epidemiology of Adenomyosis. Semin Reprod Med. 2020; 38(2-03): 89–107.
- Zannoni L, Del Forno S, Raimondo D, et al. Adenomyosis and endometriosis in adolescents and young women with pelvic pain: prevalence and risk factors. Minerva Pediatr (Torino). 2024; 76(1): 57–63.
- Exacoustos C, Lazzeri L, Martire FG, et al. Ultrasound Findings of Adenomyosis in Adolescents: Type and Grade of the Disease. J Minim Invasive Gynecol. 2022; 29(2): 291–299.e1.
- Donnez O, Orellana R, Van Kerk O, et al. Invasion process of induced deep nodular endometriosis in an experimental baboon model: similarities with collective cell migration? Fertil Steril. 2015; 104(2): 491–7.e2.
- Khan KN, Kitajima M, Hiraki K, et al. Involvement of hepatocyte growth factor-induced epithelial-mesenchymal transition in human adenomyosis. Biol Reprod. 2015; 92(2): 35.
- Zhai J, Vannuccini S, Petraglia F, et al. Adenomyosis: Mechanisms and Pathogenesis. Semin Reprod Med. 2020; 38(2-03): 129–143.
- Schrager S, Yogendran L, Marquez CM, et al. Adenomyosis: Diagnosis and Management. Am Fam Physician. 2022; 105(1): 33–38.
- Harmsen MJ, Van den Bosch T, de Leeuw RA, et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound Obstet Gynecol. 2022; 60(1): 118–131.
- Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006; 20(4): 511–521.
- Brosens I, Gordts S, Habiba M, et al. Uterine Cystic Adenomyosis: A Disease of Younger Women. J Pediatr Adolesc Gynecol. 2015; 28(6): 420–426.
- Van den Bosch T, Dueholm M, Leone FPG, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015; 46(3): 284–298.
- Celli V, Dolciami M, Ninkova R, et al. MRI and Adenomyosis: What Can Radiologists Evaluate? Int J Environ Res Public Health. 2022; 19(10).
- Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009; 3(3): e123–e130.
- Vannuccini S, Meleca C, Toscano F, et al. Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding. Reprod Biomed Online. 2024; 48(5): 103768.
- Martire FG, Lazzeri L, Conway F, et al. Adolescence and endometriosis: symptoms, ultrasound signs and early diagnosis. Fertil Steril. 2020; 114(5): 1049–1057.
- Agostinho L, Cruz R, Osório F, et al. MRI for adenomyosis: a pictorial review. Insights Imaging. 2017; 8(6): 549–556.
- Millischer AE, Santulli P, Da Costa S, et al. Adolescent endometriosis: prevalence increases with age on magnetic resonance imaging scan. Fertil Steril. 2023; 119(4): 626–633.
- Sadłocha M, Toczek J, Major K, et al. Endometriosis: Molecular Pathophysiology and Recent Treatment Strategies-Comprehensive Literature Review. Pharmaceuticals (Basel). 2024; 17(7).
- Drosdzol-Cop A, Niziński K, et al. Rekomendacje Sekcji Ginekologii Dziecięcej i Dziewczęcej Polskiego Towarzystwa Ginekologów i Położników dotyczące diagnostyki i leczenia endometriozy u dziewcząt. Ginekologia i Perinatologia Praktyczna. 2024; 9(1): 26–31.
